GRI GRI Bio Inc

Price (delayed)

$1.74

Market cap

$505,200

P/E Ratio

0.01

Dividend/share

N/A

EPS

$208.91

Enterprise value

-$3.43M

Highlights
GRI Bio's EPS has soared by 195% YoY and by 157% from the previous quarter
The net income has plunged by 152% YoY but it has grown by 2% from the previous quarter

Key stats

What are the main financial stats of GRI
Market
Shares outstanding
290,345
Market cap
$505,200
Enterprise value
-$3.43M
Valuations
Price to earnings (P/E)
0.01
Price to book (P/B)
0.15
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$11.86M
EBITDA
-$11.85M
Free cash flow
-$9.09M
Per share
EPS
$208.91
Free cash flow per share
-$28.61
Book value per share
$11.38
Revenue per share
$0
TBVPS
$14.45
Balance sheet
Total assets
$4.59M
Total liabilities
$1.79M
Debt
$152,000
Equity
$2.8M
Working capital
$2.75M
Liquidity
Debt to equity
0.05
Current ratio
2.64
Quick ratio
2.44
Net debt/EBITDA
0.33
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-290.5%
Return on equity
-548.1%
Return on invested capital
N/A
Return on capital employed
-407.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GRI stock price

How has the GRI Bio stock price performed over time
Intraday
5.45%
1 week
10.83%
1 month
596%
1 year
-94.01%
YTD
-35.43%
QTD
-9.38%

Financial performance

How have GRI Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$12.29M
Net income
-$12.77M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 152% YoY but it has grown by 2% from the previous quarter
GRI Bio's operating income has decreased by 8% from the previous quarter

Growth

What is GRI Bio's growth rate over time

Valuation

What is GRI Bio stock price valuation
P/E
0.01
P/B
0.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GRI Bio's EPS has soared by 195% YoY and by 157% from the previous quarter
The price to book (P/B) is 94% lower than the last 4 quarters average of 2.7

Efficiency

How efficient is GRI Bio business performance
The company's return on assets has shrunk by 130% YoY but it rose by 16% QoQ
GRI's ROE is down by 50% YoY but it is up by 31% QoQ

Dividends

What is GRI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GRI.

Financial health

How did GRI Bio financials performed over time
GRI's total assets is 156% more than its total liabilities
The current ratio has surged by 159% year-on-year and by 142% since the previous quarter
GRI's total assets has soared by 119% YoY and by 55% from the previous quarter
GRI Bio's debt is 95% less than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.